Supriya Lifescience Ltd

Supriya Lifesci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Supriya Lifescience Ltd

₹ 402 2.03%
24 Apr - close price
supriyalifescience.com BSE: 543434 NSE : SUPRIYA
About

Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.[1]

Key Points

Niche Offerings
The Co. has a niche product basket of 38 APIs. [1] It offers a product mix of various therapeutic segments such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics, Anti- Asthmatics etc. It has been the largest exporter of products in anti-histamine, anesthetics and anti-asthma therapies. [2]

Website BSE NSE
  • Market Cap ₹ 3,244 Cr.
  • Current Price ₹ 402
  • High / Low ₹ 406 / 214
  • Stock P/E 26.9
  • Book Value ₹ 93.6
  • Dividend Yield 0.15 %
  • ROCE 18.6 %
  • ROE 13.7 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.9%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
81 132 77 150 117 181 101 112 105 142 132 140 140
55 65 61 70 79 106 70 84 91 87 88 108 99
Operating Profit 26 67 15 80 38 75 31 29 14 55 44 32 41
OPM % 32% 51% 20% 53% 33% 42% 31% 25% 13% 39% 34% 23% 30%
4 2 2 1 5 4 2 3 3 2 3 2 3
Interest 1 1 1 1 1 1 1 1 1 1 1 0 0
Depreciation 5 2 2 2 3 3 3 3 3 3 4 4 4
Profit before tax 25 66 14 78 40 75 30 27 13 53 43 30 40
Tax % 36% 26% 45% 25% 1% 39% 16% 39% 25% 28% 33% 20% 26%
16 49 8 58 40 46 25 17 10 38 29 24 30
EPS in Rs 2.14 6.63 1.06 7.96 4.93 5.74 3.14 2.09 1.18 4.75 3.54 2.97 3.70
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
184 213 278 312 391 530 461 554
166 191 213 213 218 316 332 382
Operating Profit 17 22 65 98 173 214 129 173
OPM % 9% 10% 23% 32% 44% 40% 28% 31%
7 9 8 11 5 8 9 10
Interest 12 11 10 7 4 4 3 2
Depreciation 5 5 5 6 7 10 12 15
Profit before tax 8 14 57 96 167 207 123 166
Tax % 30% 40% 31% 24% 26% 27% 27%
6 9 39 73 124 152 90 120
EPS in Rs 3.87 5.96 26.93 50.11 16.89 18.86 11.17 14.96
Dividend Payout % 0% 0% 0% 20% 3% 3% 5%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 14%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: 59%
3 Years: 7%
TTM: 23%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 84%
Return on Equity
10 Years: %
5 Years: 32%
3 Years: 28%
Last Year: 14%

Balance Sheet

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 15 15 15 15 15 16 16 16
Reserves 31 40 79 134 254 600 683 737
140 130 90 82 72 27 22 6
55 60 69 105 105 92 98 84
Total Liabilities 241 245 253 336 445 735 820 843
89 91 85 99 100 190 262 258
CWIP 36 34 35 40 79 43 68 116
Investments 0 0 0 0 0 0 25 57
117 120 133 197 267 502 466 412
Total Assets 241 245 253 336 445 735 820 843

Cash Flows

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
27 28 49 117 76 49 66
-27 -5 5 -25 -47 -60 -133
-2 -20 -50 -29 -15 150 -3
Net Cash Flow -2 3 4 62 15 139 -70

Ratios

Figures in Rs. Crores

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 99 92 79 60 69 79 67
Inventory Days 113 85 77 130 206 172 234
Days Payable 121 112 110 130 145 91 130
Cash Conversion Cycle 91 64 45 61 130 160 171
Working Capital Days 119 97 96 49 94 132 181
ROCE % 14% 37% 50% 60% 43% 19%

Shareholding Pattern

Numbers in percentages

7 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
68.24% 68.24% 68.24% 68.24% 68.24% 68.28% 68.30% 68.30% 68.30% 68.30%
10.30% 7.13% 5.99% 6.79% 6.24% 5.66% 5.73% 5.35% 4.56% 5.37%
7.90% 7.73% 10.33% 8.88% 7.89% 7.65% 7.54% 7.17% 5.39% 5.30%
13.56% 16.90% 15.44% 16.09% 17.62% 18.43% 18.43% 19.19% 21.77% 21.04%
No. of Shareholders 55,29282,57886,85394,59496,99895,60593,47892,99195,92987,980

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls